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Abstract
Several studies suggest that human longevity appears to be linked inextricably with optimal functioning of the
immune system, suggesting that specific genetic determinants may reside in loci that regulate the immune re-
sponse, as human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genes. It has been
suggested that longevity is associated with positive selection of alleles (i.e., HLA-DR11) or haplotypes (i.e., HLA-
B8,DR3) that confer resistance to infectious disease(s). On the other hand, the cytolytic activity of natural killer
(NK) cells is controlled by activating and inhibitory cell-surface receptors, including KIR. The genetic diversity of
the KIR loci with respect to successful aging has been analyzed only in one study performed in the Irish popu-
lation. Although two KIR genes (2DS3, 2DL5) displayed an initial increased frequency in the aged group, the
significance of this association was lost when repeated in a second cohort. We have evaluated by polymerase chain
reaction–sequence-specific primers (PCR-SSP) HLA-DRB1 and KIR receptors=HLA ligands frequencies in cente-
narians and controls from Sicily. Our results demonstrate an increase of the HLA DRB1*18 allele in male cente-
narians ( p¼ 0.0266, after Bonferroni correction). Concerning KIR, no significant difference was observed after
Bonferroni correction. However, our findings suggest that HLA=KIR=longevity associations are population spe-
cific, being heavily affected by the population-specific genetic and environmental history. This kind of study is
important to better understand aging and longevity, hence enhancing the planning of antiaging strategies.
Introduction
Human longevity appears to be inextricably linkedwith optimal functioning of the immune system, sug-
gesting that specific genetic determinants may reside in loci
that regulate the immune response, as human leukocyte
antigen (HLA), cytokine networks, and killer cell immuno-
globulin-like receptor (KIR).1 The studies performed on the
association between longevity and HLA (the human major
histocompatibility complex [MHC]) are generally difficult to
interpret, owing to major methodological problems. How-
ever, some of these studies, which are well designed and
performed and support suggestions derived from the mouse
studies on MHC effects on longevity.2,3 These studies sug-
gest that longevity is associated with positive selection of
alleles (i.e., HLA-DR11) or haplotypes (i.e., HLA-B8,DR3) that
confer resistance to infectious diseases, respectively, via
peptide presentation or via antigen nonspecific control of
immune response. It is noteworthy that these associations are
mostly gender related.3,4
In our previous case–control studies, we have demon-
strated that both HLA-DR and -DQ alleles are not associated
with longevity in the Sardinian population. On the other
hand, association studies are subjected to a number of pos-
sible confounding factors (as part of the homogeneity of the
population in terms of geographic origin).5,6
Another crucial role is played by the KIRs in the regula-
tion of innate immune response. They are glycoproteins ex-
pressed on the cell surface of natural killer (NK) cells and
subsets of T cells. These polymorphic receptors interact with
specific motifs on HLA class I molecules, modulate NK cy-
tolytic activity, and are encoded by genes located on chro-
mosome 19q13.4.7–9
The KIR gene family represents a highly polymorphic
class of receptor-encoding genes, which have displayed
considerable allelic diversity, and it is postulated that KIR
polymorphism arises from both the occurrence of random
point mutations and recombination between homologous
KIR genes.10,11 At present, approximately 16 expressed KIR
genes have been identified and these are classified into
four major groups (KIR2DS, 3DS, 2DL, 3DL) on the basis of
the structural organization and function of the receptors
they encode.12 In addition, two KIR pseudogenes have been
identified.9,13 These are named KIR2DP1 and KIR3DP1,
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reflecting the high sequence homology they share with two-
domain and three-domain KIR genes, respectively.
On the basis of gene content, two groups of KIR haplotype
have been defined as A and B. Common to both groups of
haplotypes are the ‘‘framework genes’’: KIR3DL2, KIR3DL3,
and KIR2DL4.14 Group A haplotypes contain not more than
nine loci, which include KIR2DL1, 2DL3, 2DL4, 2DS4, 3DL1,
3DL2, 3DL3, 2DP1, and 3DP1. In contrast, the group B
haplotypes are more diverse and have several genes coding
activating receptors.
Several studies have associated KIR genes with disease
susceptibility, immune responsiveness, and events following
allogenic transplantation. Recent reports have implicatedKIRs
in affecting the outcome of hematopoietic stem cell transplan-
tation.15 The genetic diversity of the KIR loci with respect to
successful aging has been analyzed only in one study per-
formed in the Irish population. Although, two KIR genes
(2DS3, 2DL5) displayed an initial increased frequency in the
aged group, the significance of this association was lost when
repeated in a second cohort.16
To validate (in our homogeneous population) the gender-
related associations between HLA-DRB1 genes and longevity
observed in other Caucasoid populations, and to ascertain
whether a particular repertoire of KIR receptors is associated
with successful aging, we have evaluated HLA-DRB1 and
KIR genotypes in centenarians and controls from Sicily.
Materials and Methods
Subjects
We have genotyped 77 centenarians and 299 healthy con-
trols for HLA-DRB1 and 44 centenarians and 57 healthy con-
trols for KIR receptors=HLA ligands, all from Palermo and
surrounding municipalities in western Sicily, Italy. The age of
Sicilian centenarians was verified by archival records at the
municipal offices and=or church registries. We paid particular
attention to the concordance between reported age and per-
sonal chronologies (age of marriage and of military service for
men, age of first and last pregnancy forwomen, age of children,
among others). This group did not have any cardiac risk factors
or major age-related diseases (e.g., coronary heart disease, se-
vere cognitive impairment, severe physical impairment, clini-
cally evident cancer, or renal insufficiency), although some had
decreased auditory and visual acuity, as would be expected.17
Most biochemical parameters, including cholesterol and tri-
glycerides, were in the normal range. The healthy control
group of 299 subjects was recruited amongst students or staff
personnel who were checked and judged to be in good health
on the basis of their clinical history and blood tests (complete
blood cell count, erythrocyte sedimentation rate, glucose, urea
nitrogen, creatinine, electrolytes, C-reactive protein, liver
function tests, iron, proteins, cholesterol, triglycerides). Because
immigration and intermarriage have historically been rare, the
Sicilian ethnicity of all participants was established if all four
grandparents were born in western Sicily. The study was ap-
proved by the University Hospital Ethics Committee, and
written informed consent was obtained from all participants.
HLA and KIR typing
The salting-out method was used to extract the DNA,
following the standard protocol.18 The DNA samples were
typed for class II HLA alleles and KIR receptors =HLA li-
gands by polymerase chain reaction–sequence-specific pri-
mer (PCR-SSP; One Lambda, Inc. Canoga Park, CA) and
KIR-TYPE=Epitop-TYPE (BAG Health Care GmbH, Lich,
Germany). The KIR-TYPE kit was designed to identify 14 KIR
genes (2DL1, 2DL2, 3DL1, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3,
2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1), 2 pseudogenes (2DP1
and 3DP1) and the common variants of KIR2DL5 (KIR2DL5A,
KIR2DL5B), the KIR2DS4 allele (*001=002 and *003), and
KIR3DP1 allele (*001=002 and *003), whereas the Epitop-
TYPE kit was used to detect the alleles of the HLA specifi-
cities HLA-Cw Asn80, HLA-Cw Lys80, HLA-B Bw4Threo,
HLA-B Bw4 Iso, and HLA-A Bw4. The PCR reaction was
amplified using a PCR thermal sequencer (Mycicler, Biorad,
Milan, Italy). After the PCR process, the amplified DNA
fragments were separated by agarose gel electrophoresis
(2–2.5%), 0.5–1% Tris=borate=EDTA buffer, and ethidium
bromide (0.5mg=mL). All the subjects positive for the HLA-
DR3 subtype, HLA-DRB1*17, were typed for HLA-B8 by
micro-SSP (One Lambda, Inc.) to identify carriers of HLA-
B8,DR3(DR17) haplotype, which is part of the 8.1 ancestral
haplotype (AH 8.1) HLA-A1, Cw7, B8, TNFAB*a2b3,
TNFN*S, C2*C, Bf*s, C4A*Q0, C4B*1, DRB1*0301(DR17),
DRB3*0101, DQA1*0501, DQB1*0201.4
Statistical analysis
Allele frequencies were evaluated by gene count, and 22
tables were constructed to determine the statistical signifi-
cance (chi-squared test with Yates correction) of differences
in allele frequency for the HLA-DR polymorphisms and KIR
genes between centenarians and controls. The p values ob-
tained were multiplied for the number of alleles under study
(Bonferroni correction), i.e., 14 for DR typing and 19 KIR
typing. The data were tested for the goodness of fit between
the observed and expected genotype values and their fit to
Hardy–Weinberg equilibrium (HWE).
Results
The frequencies of the of HLA-DRB1* alleles and KIR
genes under investigation were consistent with those pre-
dicted by the HWE. Table 1 shows the HLA-DRB1* allele
frequencies in 299 controls and 77 centenarians. We found an
increase of HLA DRB1*18 allele in male centenarians
( p¼ 0.0019), the increase remained significant after Bonfer-
roni correction ( p¼ 0.0266). Concerning the other alleles, no
significant differences were observed between centenarians
and controls (both in women and in men). A sample of
subjects (38 healthy controls and 44 centenarians) was typed
for HLA-B8, but there were no significant differences be-
tween centenarians and controls concerning the HLA-
B8,DR3 phenotype (data not shown).
Concerning KIR genes, Table 2 shows the KIR gene fre-
quencies in 57 healthy controls and 44 centenarians. Only a
significant decrease of the 2DP1 KIR gene in centenarians was
observed ( p¼ 0.03), and it was no longer significant after
Bonferroni correction. No significant difference was obtained
stratifying the subjects by gender (data not shown). Table 3
shows HLA ligands frequencies observed in 57 healthy con-
trols and 44 centenarians. No significant difference was ob-
served in centenarians and controls for HLA ligands.
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Analyzing the distributions of ‘‘A’’ haplotype, ‘‘B’’ haplotype,
and ‘‘A=B’’ haplotype, there are not significant differences
(data not shown). However, the A haplotype predominates in
the Sicilian population (26% vs. 0% in healthy controls).
Discussion
Longevity is the result of several interacting factors, in-
cluding genetic, environmental, and behavioral compo-
nents.19 Several studies suggest that human longevity is
inextricably linked to the optimal function of the immune
system. Hence, genetic determinants of longevity might reside
in the polymorphisms for genes that regulate immune re-
sponses as HLA and KIR.1 HLA polymorphisms have been
the focus of a vast number of aging association studies, in
contrast to only two studies of KIR genes.16 Conflicting results
have been obtained regarding HLA, suggesting that the ob-
served age-related differences in the frequency of HLA anti-
gens are due to bias. The studies performed on the association
between longevity and HLA are generally difficult to inter-
pret, owing to major methodological problems. However, as
reported Caruso et al.,2,3 some that were well designed and
performed suggest an HLA effect on longevity. In studies
performed in Caucasoids, an increase in HLA-DRB1*11
in Dutch women over 85 years was observed.20 The same
laboratory performed a further study and, by using a ‘‘birth-
place-restricted comparison’’ in which the origin of all the
subjects was ascertained, the authors were able to confirm
that aging in women was positively associated with HLA-
DR5.21 Two French studies confirmed the relevance of HLA-
DR11 to longevity in aged populations.22,23 This increase is
consistent with the protective effects of this allele in viral
diseases, as HLA-DR5, or its subtype HLA-DR11, frequencies
have been shown to be decreased in some viral diseases.2,3
An association between longevity and the haplotype AH
8.1 seems to emerge. An excess of this AH in the oldest old
men has been reported in French and in North Ireland
populations.24,25 This association appears to be gender spe-
cific. In fact, a Greek study showed a significant decrease of
Table 1. HLA-DRB1* Allele Frequencies in 299 Controls (171 Women and 128 Men)
and in 77 Centenarians (51 Women and 26 Men) from Sicily
Controls Centenarians
HLA All Women Men All Women Men
DRB1*01 43 (14.4%) 25 (14.5%) 18 (14%) 9 (12%) 7 (13.7%) 2 (8.7%)
DRB1*15 74 (24.7%) 39 (22.6%) 35 (27.3%) 12 (16.2%) 7 (13.7%) 5 (21.7%)
DRB1*16 20 (6.6%) 8 (4.6%) 12 (9.3%) 3 (4%) 1 (2%) 2 (8.7%)
DRB1*17 70 (23.4%) 40 (23.2%) 30 (23.4%) 15 (20%) 12 (23.5%) 3 (13%)
DRB1*18 2 (0.6%) 2 (1.1%) 0 6 (8.1%) 3 (5.8%) 3 (13%)a
DRB1*4 62 (20.7%) 32 (18.6%) 30 (23.4%) 15 (20%) 11 (21.5%) 4 (17.4%)
DRB1*10 12 (4%) 6 (3.4%) 6 (4.6%) 3 (2.7%) 3 (5.9%) 0
DRB1*11 117 (39.1%) 73 (42.4%) 44 (34.3%) 27 (36.5%) 19 (37.2%) 8 (34.8%)
DRB1*12 10 (3.3%) 10 (5.8%) 0 3 (4%) 2 (4%) 1 (4.3%)
DRB1*13 43 (14.4%) 26 (15.1%) 17 (13.3%) 17 (23%) 13 (25.5%) 4 (17.4%)
DRB1*14 21 (7%) 13 (7.5%) 8 (6.2%) 7 (9%) 4 (7.9%) 3 (13%)
DRB1*7 37 (16.1%) 24 (11.6%) 13 (10.1%) 9 (12%) 5 (9.8%) 4 (17.4%)
DRB1*08 4 (1.3%) 2 (1.1%) 2 (1.5%) 1 (1.3%) 1 (1.9%) 0
DRB1*09 1 (0.3%) 1 (0.5%) 0 2 (2.7%) 1 (1.9) 1 (4.3)
ap¼ 0.0019 by chi-squared Yates correction, p¼ 0.0266 after Bonferroni’s correction.
HLA, Human leukocyte antigen.
Table 2. KIR Gene Frequencies Observed





(n¼ 44) p value
2DL1 56 (98.2%) 42 (95.5%)
2DL2 40 (70%) 28 (63.6%)
2DL3 39 (68.4%) 30 (68%)
2DL4 56 (98.2%) 43 (97.7%)
2DL5A 10 (17.5%) 10 (22.7%)
2DL5B 18 (31.5%) 10 (22.7%)
2DS1 28 (49.1%) 19 (43.2%)
2DS2 36 (63.1%) 29 (66%)
2DS3 30 (52.6%) 24 (54.5%)
2DS4001=002 10 (17.5%) 8 (18%)
2DS4003=007 43 (75.4%) 32 (72.7%)
2DS5 24 (42.1%) 16 (36.3%)
3DL1 51 (89.5%) 39 (88.6%)
3DL2 54 (94.7%) 42 (95.5%)
3DL3 56 (98.2%) 44 (100%)
3DS1 25 (43.8%) 21 (47.7%)
2DP1 55 (96.5%) 37 (84%) 0.03a
3DP1001=004 2 (3.5%) 4 (9%)
3DP1003 53 (93%) 37 (84%)
aUncorrected p value by chi-squares Yates correction.
KIR, Killer cell immunoglobulin-like receptor.
Table 3. The HLA Ligands Frequencies Observed





(n¼ 44) p value
C1 16 (28%) 19 (43%) N.S.
C2 17 (30%) 11 (25%) N.S.
C1,C2 24 (42%) 14 (32%) N.S.
HLA, Human leukocyte antigen; N.S., not significant.
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AH 8.1 in aged women.26 Thus, immune dysfunctions of AH
8.1 should contribute to early morbidity and mortality in
elderly women, to more susceptibility to autoimmune dis-
eases than men, and to longevity in elderly men.2–4
These associations are gender-related, but it is not unex-
pected on the basis of available data on the genetics of lon-
gevity, showing that the association of longevity with
particular alleles may be found only in one gender.27 How-
ever, in a longitudinal study, in which a total of 919 subjects
aged 85 and older were HLA-typed and followed up for at
least 5 years, no HLA association with mortality was found.
21 Positive studies need confirmation in different Caucasoid
populations with different ethnic backgrounds and=or rep-
lication in a new cohort of oldest old from the same popu-
lation. In Sardinian centenarians, we did not observed the
associations demonstrated in the other well-planned and
designed studies discussed above.5 One study set out to
specifically confirm the previously reported increase in the
frequency of AH 8.1 in aged men of the northern Irish
population,25 but did not reveal any statistically significant
haplotype frequency differences between the aged cohort of
individuals compared to the younger controls. However, a
striking decrease was observed when the aged women
(13.1%) were compared to the control women (17.8%).28
A pivotal role in the innate immune response is also
played by NK cells in successful aging. In particular, some
studies have showed that decreased NK cell function is
associated with an increased incidence of infectious diseases
both in aged humans 29 and in mice,30 highlighting the im-
portance of a well-preserved NK cell function in old age. The
elderly (>85 years) with low numbers of NK cells were
reported to have three times the mortality risk in the first
2 years of follow up than those with high NK cell numbers.31
In addition, high NK cytotoxicity in aged people is related
both to a low incidence of respiratory tract infections and to
good development of protective antibody titers in response
to influenza vaccination.32 Hence, preserved NK cytotoxicity
should be considered a biomarker of healthy aging and
longevity, whereas low NK cytotoxicity is a predictor of
morbidity and mortality due to infections.
However, concerning KIR genes, the potential role of KIR
diversity in immunosenescence and longevity has been in-
vestigated only in the Irish population. Although, two KIR
genes (2DS3, 2DL5) displayed an initial increased frequency
in the aged group, the significance of this association was
absent when repeated in a second cohort.16 Both activating
and inhibitory KIR genes encode receptors with immune
functions that clearly have the potential to optimize NK cell
activity in the elderly, thereby contributing to prolonged life
span. Hence, the increased prevalence of such a KIR gene in
the healthy aged may reflect a role for the activating receptor
it encodes in providing an improved level of innate immune
protection against virus infection and cancer.
In this study we evaluated the frequencies of genes
HLA-DRB1 and KIR in centenarians and controls from Sicily.
Our results demonstrate an increase of HLA DRB1*18 allele
in male centenarians compared to controls even after Bon-
ferroni correction. The frequency of the HLA-B8,DR3 hap-
lotype is very low and not significant both in centenarians
and in controls as well as in literature data.33 In regard to
KIR genes, only a significant decrease of the 2DP1 KIR
gene in centenarians was observed, which was no longer
significant after Bonferroni correction. As in other Caucasian
populations, the A haplotype was found to be prevalent in
Sicilian population. Thus, results obtained show that only an
HLA allele (DRB1*18) is associated with longevity. To con-
firm this association, a further study in a new cohort of
centenarians and controls is needed. On the other hand, no
significant association between successful aging and KIR
gene content was observed in this Sicilian population.
Although, the present study does not support a role for KIR
diversity in aging, considerably more research is required to
elucidate the precise role that NK cells play in longevity. It is
conceivable that epistatic interactions between particular
HLA and KIR haplotypes may contribute to the generation of
a dynamic immune response that supports successful aging,
whereas certain other haplotype combinations may produce
suboptimal levels of immunity and reduced life span.
Present and previous findings suggest that HLA=KIR=
longevity associations are population specific, being heavily
affected by the population-specific genetic and environmen-
tal history. On the other hand, our group has performed
several studies showing that inflammatory gene variants are
associated with longevity.34,35 In our opinion, inflammatory
genes are more relevant than immune response genes in the
control of successful aging. However, this kind of study is
important to better understand aging and longevity, hence
enhancing the planning of antiaging strategies.36–38
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